Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2003
07/17/2003US20030134350 Zinc finger domain recognition code and uses thereof
07/17/2003US20030133988 Immunomodulation accomplished by administration of immunomodulatory polynucleotide/microcarrier complexes comprising 3-6 mer immunomodulatory oligonucleotides
07/17/2003US20030133981 Extended release formulations of erythromycin derivatives
07/17/2003US20030133980 Biocompatible polymer blends and uses thereof
07/17/2003US20030133969 Topical agent capable of disrupting membrane or protein conformation in a target cell, tissue or microbe; does not contain nonoxynol-9, benzalkonium chloride or menfegol
07/17/2003US20030133941 Method of separating protective components of bordetella pertussis
07/17/2003US20030133940 Medicaments for chemotherapeutic treatment of disease
07/17/2003US20030133934 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method
07/17/2003US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen.
07/17/2003US20030133929 Draining blood from the animal, separating blood cells from plasma, contacting plasma with a solvent in which lipids are soluble, separating plasma to reintroduce it into the animal, separating dissolved lipids
07/17/2003US20030133925 Monobactam compositions and methods of use thereof
07/17/2003US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes
07/17/2003US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response
07/17/2003CA2473226A1 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
07/17/2003CA2472585A1 Drug mixture with enhanced dissolution rate
07/17/2003CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
07/17/2003CA2472111A1 Human mast cell-expressed membrane proteins
07/17/2003CA2472049A1 Dominant negative proteins and methods thereof
07/17/2003CA2471951A1 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
07/17/2003CA2471874A1 Compositions and methods for hydroxylating epothilones
07/17/2003CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains
07/17/2003CA2471504A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
07/17/2003CA2471458A1 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same
07/17/2003CA2471204A1 Inhibitors of dipeptidyl peptidase iv
07/17/2003CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors
07/17/2003CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
07/17/2003CA2467083A1 Viral capsid assembly intermediates
07/16/2003EP1327683A2 Human papilloma virus inhibition by a hairpin ribozyme
07/16/2003EP1327448A1 Homeostasis-maintaining agents
07/16/2003EP1326990A2 Packaging of positive-strand rna virus replicon particles
07/16/2003EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137
07/16/2003EP1326971A2 Proteins and nucleic acids encoding same
07/16/2003EP1326961A2 Compositions and methods for inducing specific cytolytic t cell responses
07/16/2003EP1326895A1 Monoclonal antibodies directed against hepatitis b viruses
07/16/2003EP1326894A2 Novel tumor-associated marker
07/16/2003EP1326893A2 Plasma fraction containing bikunin, method for the production thereof and use of the same
07/16/2003EP1326873A1 Combinatorial libraries of monosaccharides
07/16/2003EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists
07/16/2003EP1326867A2 Bridged piperazine derivatives
07/16/2003EP1326865A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
07/16/2003EP1326852A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use
07/16/2003EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
07/16/2003EP1326843A1 Pyrazole derivatives for the treatment of viral diseases
07/16/2003EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326836A1 Process for making 3-amino-2-chloro-4-methylpyridine
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003EP1326637A2 Vaccine comprising heat stress proteins from herbaceous plants
07/16/2003EP1326636A2 Vaccine composition
07/16/2003EP1326635A2 Pharmaceutical composition for immunisation against aids
07/16/2003EP1326633A1 Composition comprising immunogenic microparticles
07/16/2003EP1326632A2 Agents for the treatment of viral infections
07/16/2003EP1326629A2 Methods and compositions for promoting the maturation of monocytes
07/16/2003EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
07/16/2003EP1326612A1 Gatifloxacin pentahydrate
07/16/2003EP1326611A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
07/16/2003EP1326610A2 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
07/16/2003EP1326608A1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers
07/16/2003EP1326607A1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003EP1326603A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
07/16/2003EP1326599A2 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin
07/16/2003EP1326594A2 Ribavirin-pegylated interferon alfa hcv combination therapy
07/16/2003EP1326589A2 Nanoparticles
07/16/2003EP1326584A1 Delivery system and method of treating or preventing otitis media
07/16/2003EP1326583A1 Medication delivery devices
07/16/2003EP1261587B1 Stilbene derivatives, their preparation and their use as antiviral agents
07/16/2003EP1155000B1 2-aminopyridines containing fused ring substituents
07/16/2003EP1084104B1 Nitric oxide synthase inhibitors
07/16/2003EP1070069B1 Bicyclic hydroxamic acid derivatives
07/16/2003EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1
07/16/2003EP0975354A4 Ligand/lytic peptide compositions and methods of use
07/16/2003EP0852586B1 Use of a 24 kDa protein for treating and diagnosing an HCV Infektion
07/16/2003EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
07/16/2003EP0789767B1 A method for producing purified papillomavirus proteins
07/16/2003EP0759935B1 Recombinant papilloma virus l1
07/16/2003CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof
07/16/2003CN1430621A New process for preparation of vinyl-pyrrolidinone cephalosporine derivatives
07/16/2003CN1430618A Thiazine oxazolidinone
07/16/2003CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha
07/16/2003CN1430600A 7-and 9-carbamate, urea, thiourea, thiocarbamate and heteroaryl-amino substituted tetracycline compounds
07/16/2003CN1430597A Novel MMP-2/MMP-9 inhibitors
07/16/2003CN1430518A Use of lactobacillus casei in immunostimulatory peptides
07/16/2003CN1430509A Method for controlling septemia shock
07/16/2003CN1429907A Method of obtaining transgenic rape chloroplast plant for producing foot-and-mouth disease vaccine
07/16/2003CN1429906A Method of obtaining transgenic mountain lettuce chloroplast plant for producing foot-and-mouth disease vaccine
07/16/2003CN1429836A Hepatitis C virus high change region 1 synthetic peptide and its use
07/16/2003CN1429832A Nucleotide specific to O-antigen of shigella boydii 7
07/16/2003CN1429826A Preparation method and use of sodium Penciclovir sodium hydrate
07/16/2003CN1429825A Guanine compound, its preparation method and application
07/16/2003CN1429625A Medicine for treating chronic hepatitis B
07/16/2003CN1429621A Edible fungus formula for treating hepatitis disease and its preparation method
07/16/2003CN1429617A Application of castor bean in preparation of medicine for disease related to sex
07/16/2003CN1429607A Red sage root-astragalus root particles for liver softening
07/16/2003CN1429590A Transaminase lowering capsule
07/16/2003CN1429588A Medicine for treating ulceration-type tuberculosis
1 ... 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 ... 1798